Jacob Kokoshka
About Jacob Kokoshka
Jacob Kokoshka is a Document Control Specialist at Bristol Myers Squibb and a Clinical Laboratory Assistant at Atlantic Health, with a background in biology and extensive experience in research and documentation.
Current Positions
Jacob Kokoshka is currently employed at Bristol Myers Squibb as a Document Control Specialist based in Summit, New Jersey. In addition, he holds a position at Atlantic Health in Morristown, New Jersey, where he functions as a Clinical Laboratory Assistant. Balancing these roles, Jacob contributes to both institutions by providing essential services related to document control and clinical laboratory operations.
Previous Experience at Columbia University Irving Medical Center
Jacob Kokoshka has held multiple positions at Columbia University Irving Medical Center in New York, New York. In 2018, he served as a Research Assistant for three months. Prior to that, in 2017, he undertook a three-month role as a Medical Intern. These experiences helped him gain valuable insights and experience in medical research and clinical practices.
Academic Background and Qualifications
Jacob Kokoshka studied at Columbia University in the City of New York, where he completed a Bachelor of Arts in Biology/Biological Sciences, General from 2017 to 2020. Additionally, he obtained an Associate of Science in Biology: Pre-professional Track from County College of Morris, where he studied from 2015 to 2016. His educational background has equipped him with a solid foundation in biological sciences.
Work Experience at County College of Morris and Lightening Energy
In 2016, Jacob Kokoshka worked as a Peer Tutor at County College of Morris for three months in Randolph, New Jersey. Later that year, he spent two months as a Research Assistant at Lightening Energy in Dover, New Jersey. These roles allowed him to develop skills in peer education and research.
Achievements in Document Control and Cell Therapy Development
Jacob Kokoshka has participated in a successful FDA inspection, leading to the approval of the first CAR T-cell therapy for multiple myeloma. As a Subject Matter Expert in documentation systems, he manages business-critical documents inspected by both domestic and international regulatory authorities. He has also supported Cell Therapy Development Operations by coordinating GMP/GDP documentation activities and effectively communicating with various stakeholders.